A multicentre, observational, retrospective real world study assessing the effectiveness of bezlotoxumab for the prevention of recurrent Clostridioides difficile infection
Latest Information Update: 24 Jun 2020
At a glance
- Drugs Bezlotoxumab (Primary)
- Indications Clostridium difficile infections
- Focus Therapeutic Use
Most Recent Events
- 24 Jun 2020 New trial record